Clinical Decisions in AML Podcast
Explore research advancements affecting AML treatment planning in a 10-minute podcast featuring Dr. Linda J. Burns, VP and Medical Director of Health Services Research at NMDP/Be The Match.
Hematologists, oncologists, nurse practitioners, physician assistants, and other health care professionals who treat patients with AML.
- Identify cytogenetics and molecular marker testing needs at diagnosis of AML and how results can be used to determine disease risk and therapy choices for patients with AML.
- Describe how timing of HCT can effect patient outcomes.
Vice President and Medical Director, Health Services Research
National Marrow Donor Program/Be The Match
If you have any questions regarding this activity or for assistance for people with disabilities, grievances, please email email@example.com.